Logo image of BC8.DE

BECHTLE AG (BC8.DE) Stock Fundamental Analysis

Europe - FRA:BC8 - DE0005158703 - Common Stock

38.52 EUR
+1.02 (+2.72%)
Last: 9/18/2025, 7:00:00 PM
Fundamental Rating

5

Taking everything into account, BC8 scores 5 out of 10 in our fundamental rating. BC8 was compared to 69 industry peers in the IT Services industry. BC8 is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. BC8 has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

BC8 had positive earnings in the past year.
In the past year BC8 had a positive cash flow from operations.
BC8 had positive earnings in each of the past 5 years.
BC8 had a positive operating cash flow in each of the past 5 years.
BC8.DE Yearly Net Income VS EBIT VS OCF VS FCFBC8.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

1.2 Ratios

BC8 has a better Return On Assets (5.29%) than 63.77% of its industry peers.
BC8 has a Return On Equity (11.21%) which is in line with its industry peers.
BC8 has a Return On Invested Capital of 8.37%. This is comparable to the rest of the industry: BC8 outperforms 49.28% of its industry peers.
BC8 had an Average Return On Invested Capital over the past 3 years of 12.02%. This is in line with the industry average of 11.46%.
Industry RankSector Rank
ROA 5.29%
ROE 11.21%
ROIC 8.37%
ROA(3y)6.7%
ROA(5y)6.98%
ROE(3y)14.8%
ROE(5y)15.62%
ROIC(3y)12.02%
ROIC(5y)11.98%
BC8.DE Yearly ROA, ROE, ROICBC8.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

BC8's Profit Margin of 3.41% is in line compared to the rest of the industry. BC8 outperforms 53.62% of its industry peers.
BC8's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 4.91%, BC8 is in line with its industry, outperforming 46.38% of the companies in the same industry.
BC8's Operating Margin has improved in the last couple of years.
BC8's Gross Margin of 18.01% is on the low side compared to the rest of the industry. BC8 is outperformed by 78.26% of its industry peers.
In the last couple of years the Gross Margin of BC8 has grown nicely.
Industry RankSector Rank
OM 4.91%
PM (TTM) 3.41%
GM 18.01%
OM growth 3Y0.2%
OM growth 5Y6.64%
PM growth 3Y-3.72%
PM growth 5Y4.18%
GM growth 3Y1.35%
GM growth 5Y4.79%
BC8.DE Yearly Profit, Operating, Gross MarginsBC8.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BC8 is destroying value.
The number of shares outstanding for BC8 remains at a similar level compared to 1 year ago.
BC8 has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, BC8 has an improved debt to assets ratio.
BC8.DE Yearly Shares OutstandingBC8.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BC8.DE Yearly Total Debt VS Total AssetsBC8.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

BC8 has an Altman-Z score of 4.03. This indicates that BC8 is financially healthy and has little risk of bankruptcy at the moment.
BC8 has a Altman-Z score of 4.03. This is amongst the best in the industry. BC8 outperforms 86.96% of its industry peers.
BC8 has a debt to FCF ratio of 2.34. This is a good value and a sign of high solvency as BC8 would need 2.34 years to pay back of all of its debts.
BC8 has a better Debt to FCF ratio (2.34) than 72.46% of its industry peers.
A Debt/Equity ratio of 0.30 indicates that BC8 is not too dependend on debt financing.
BC8's Debt to Equity ratio of 0.30 is fine compared to the rest of the industry. BC8 outperforms 65.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 2.34
Altman-Z 4.03
ROIC/WACC0.67
WACC12.54%
BC8.DE Yearly LT Debt VS Equity VS FCFBC8.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

BC8 has a Current Ratio of 1.70. This is a normal value and indicates that BC8 is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of BC8 (1.70) is better than 81.16% of its industry peers.
A Quick Ratio of 1.42 indicates that BC8 should not have too much problems paying its short term obligations.
The Quick ratio of BC8 (1.42) is better than 73.91% of its industry peers.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.42
BC8.DE Yearly Current Assets VS Current LiabilitesBC8.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

3

3. Growth

3.1 Past

BC8 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.27%.
BC8 shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.58% yearly.
The Revenue has decreased by -1.21% in the past year.
The Revenue has been growing slightly by 3.25% on average over the past years.
EPS 1Y (TTM)-18.27%
EPS 3Y1.89%
EPS 5Y7.58%
EPS Q2Q%-20.83%
Revenue 1Y (TTM)-1.21%
Revenue growth 3Y5.93%
Revenue growth 5Y3.25%
Sales Q2Q%0.84%

3.2 Future

BC8 is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.23% yearly.
Based on estimates for the next years, BC8 will show a small growth in Revenue. The Revenue will grow by 5.35% on average per year.
EPS Next Y-4.54%
EPS Next 2Y4.29%
EPS Next 3Y6.52%
EPS Next 5Y7.23%
Revenue Next Year3.48%
Revenue Next 2Y4.97%
Revenue Next 3Y5.71%
Revenue Next 5Y5.35%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BC8.DE Yearly Revenue VS EstimatesBC8.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B 10B
BC8.DE Yearly EPS VS EstimatesBC8.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2 2.5

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 22.66, BC8 is valued on the expensive side.
The rest of the industry has a similar Price/Earnings ratio as BC8.
BC8 is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 18.16 indicates a rather expensive valuation of BC8.
BC8's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.88, BC8 is valued a bit cheaper.
Industry RankSector Rank
PE 22.66
Fwd PE 18.16
BC8.DE Price Earnings VS Forward Price EarningsBC8.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BC8 is valued a bit more expensive than 66.67% of the companies in the same industry.
BC8's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 14.42
EV/EBITDA 10.86
BC8.DE Per share dataBC8.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

BC8 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.99
EPS Next 2Y4.29%
EPS Next 3Y6.52%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.93%, BC8 has a reasonable but not impressive dividend return.
BC8's Dividend Yield is comparable with the industry average which is at 7.73.
Compared to an average S&P500 Dividend Yield of 2.38, BC8 has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.93%

5.2 History

On average, the dividend of BC8 grows each year by 16.00%, which is quite nice.
Dividend Growth(5Y)16%
Div Incr Years1
Div Non Decr Years6
BC8.DE Yearly Dividends per shareBC8.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

BC8 pays out 41.25% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of BC8 is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP41.25%
EPS Next 2Y4.29%
EPS Next 3Y6.52%
BC8.DE Yearly Income VS Free CF VS DividendBC8.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M
BC8.DE Dividend Payout.BC8.DE Dividend Payout, showing the Payout Ratio.BC8.DE Dividend Payout.PayoutRetained Earnings

BECHTLE AG

FRA:BC8 (9/18/2025, 7:00:00 PM)

38.52

+1.02 (+2.72%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)08-08 2025-08-08/bmo
Earnings (Next)11-14 2025-11-14
Inst Owners37.72%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap4.85B
Analysts80
Price Target44.02 (14.28%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.93%
Yearly Dividend0.7
Dividend Growth(5Y)16%
DP41.25%
Div Incr Years1
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.05%
Min EPS beat(2)-9.37%
Max EPS beat(2)9.48%
EPS beat(4)1
Avg EPS beat(4)-2.98%
Min EPS beat(4)-9.76%
Max EPS beat(4)9.48%
EPS beat(8)2
Avg EPS beat(8)-2.48%
EPS beat(12)4
Avg EPS beat(12)-1.49%
EPS beat(16)7
Avg EPS beat(16)0.63%
Revenue beat(2)0
Avg Revenue beat(2)-1.1%
Min Revenue beat(2)-1.25%
Max Revenue beat(2)-0.95%
Revenue beat(4)1
Avg Revenue beat(4)-0.63%
Min Revenue beat(4)-1.25%
Max Revenue beat(4)0.55%
Revenue beat(8)2
Avg Revenue beat(8)-3.48%
Revenue beat(12)5
Avg Revenue beat(12)-0.18%
Revenue beat(16)6
Avg Revenue beat(16)-4.73%
PT rev (1m)1.06%
PT rev (3m)0.11%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.08%
EPS NY rev (1m)-7%
EPS NY rev (3m)-7%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.8%
Revenue NY rev (1m)1.97%
Revenue NY rev (3m)1.52%
Valuation
Industry RankSector Rank
PE 22.66
Fwd PE 18.16
P/S 0.77
P/FCF 14.42
P/OCF 11
P/B 2.54
P/tB 5.36
EV/EBITDA 10.86
EPS(TTM)1.7
EY4.41%
EPS(NY)2.12
Fwd EY5.51%
FCF(TTM)2.67
FCFY6.93%
OCF(TTM)3.5
OCFY9.09%
SpS49.81
BVpS15.14
TBVpS7.19
PEG (NY)N/A
PEG (5Y)2.99
Profitability
Industry RankSector Rank
ROA 5.29%
ROE 11.21%
ROCE 11.8%
ROIC 8.37%
ROICexc 10.47%
ROICexgc 20.12%
OM 4.91%
PM (TTM) 3.41%
GM 18.01%
FCFM 5.36%
ROA(3y)6.7%
ROA(5y)6.98%
ROE(3y)14.8%
ROE(5y)15.62%
ROIC(3y)12.02%
ROIC(5y)11.98%
ROICexc(3y)15.84%
ROICexc(5y)15.71%
ROICexgc(3y)29.63%
ROICexgc(5y)28.23%
ROCE(3y)16.94%
ROCE(5y)16.89%
ROICexcg growth 3Y4.87%
ROICexcg growth 5Y7.72%
ROICexc growth 3Y-3.54%
ROICexc growth 5Y2.28%
OM growth 3Y0.2%
OM growth 5Y6.64%
PM growth 3Y-3.72%
PM growth 5Y4.18%
GM growth 3Y1.35%
GM growth 5Y4.79%
F-Score4
Asset Turnover1.55
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 2.34
Debt/EBITDA 1.26
Cap/Depr 69.05%
Cap/Sales 1.67%
Interest Coverage 13.51
Cash Conversion 95.99%
Profit Quality 157.36%
Current Ratio 1.7
Quick Ratio 1.42
Altman-Z 4.03
F-Score4
WACC12.54%
ROIC/WACC0.67
Cap/Depr(3y)72%
Cap/Depr(5y)67.96%
Cap/Sales(3y)1.45%
Cap/Sales(5y)1.35%
Profit Quality(3y)113.31%
Profit Quality(5y)113.66%
High Growth Momentum
Growth
EPS 1Y (TTM)-18.27%
EPS 3Y1.89%
EPS 5Y7.58%
EPS Q2Q%-20.83%
EPS Next Y-4.54%
EPS Next 2Y4.29%
EPS Next 3Y6.52%
EPS Next 5Y7.23%
Revenue 1Y (TTM)-1.21%
Revenue growth 3Y5.93%
Revenue growth 5Y3.25%
Sales Q2Q%0.84%
Revenue Next Year3.48%
Revenue Next 2Y4.97%
Revenue Next 3Y5.71%
Revenue Next 5Y5.35%
EBIT growth 1Y-17.65%
EBIT growth 3Y6.14%
EBIT growth 5Y10.1%
EBIT Next Year37.94%
EBIT Next 3Y17.48%
EBIT Next 5Y10.22%
FCF growth 1Y15.41%
FCF growth 3Y27.55%
FCF growth 5Y27.87%
OCF growth 1Y14.88%
OCF growth 3Y25.19%
OCF growth 5Y24.58%